SomaLogic, Inc.

SomaLogic, Inc. (Nasdaq: SLGC) is a proteomics company focused on protein biomarker discovery and clinical diagnostics that went public in 2021 through a business combination with CM Life Sciences III, a special purpose acquisition company sponsored by CM Life Sciences. The company filed its S-1 registration statement on October 1, 2021, with accession number 0001213900-21-051049, reflecting the completion of its SPAC merger and entry into the public markets. Operating in the life sciences and biotechnology sector, SomaLogic develops its SomaScan platform for large-scale protein measurement used in drug development and population health research. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time SPAC analytics on SLGC and thousands of other transactions.